HF
AVXL icon

HRT Financial’s Anavex Life Sciences AVXL Stock Holding History

HRT Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+39,000
New +$169K ﹤0.01% 3318

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

HRT Financial's AVXL Position: Q1 2026 in Review

HRT Financial opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 657,877 shares worth $2.02M. The stake represents 0.01% of the portfolio and ranks #1612 among its holdings. This is a return to the name: HRT Financial previously reported a position in AVXL as recently as Q3 2024.

HRT Financial first reported a position in AVXL in Q2 2022 and has held it in 4 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • HRT Financial held 657,877 shares of Anavex Life Sciences worth $2.02M as of Q1 2026.
  • Anavex Life Sciences was a new HRT Financial position in Q1 2026.
  • Anavex Life Sciences made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1612 holding.
  • HRT Financial first reported a position in Anavex Life Sciences in Q2 2022 and has held it in 4 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.